285 related articles for article (PubMed ID: 28338410)
1. Intracellular delivery of proteins by nanocarriers.
Ray M; Lee YW; Scaletti F; Yu R; Rotello VM
Nanomedicine (Lond); 2017 Apr; 12(8):941-952. PubMed ID: 28338410
[TBL] [Abstract][Full Text] [Related]
2. Direct delivery of functional proteins and enzymes to the cytosol using nanoparticle-stabilized nanocapsules.
Tang R; Kim CS; Solfiell DJ; Rana S; Mout R; Velázquez-Delgado EM; Chompoosor A; Jeong Y; Yan B; Zhu ZJ; Kim C; Hardy JA; Rotello VM
ACS Nano; 2013 Aug; 7(8):6667-6673. PubMed ID: 23815280
[TBL] [Abstract][Full Text] [Related]
3. Redox-responsive nanocapsules for intracellular protein delivery.
Zhao M; Biswas A; Hu B; Joo KI; Wang P; Gu Z; Tang Y
Biomaterials; 2011 Aug; 32(22):5223-30. PubMed ID: 21514660
[TBL] [Abstract][Full Text] [Related]
4. Protein corona change the drug release profile of nanocarriers: the "overlooked" factor at the nanobio interface.
Behzadi S; Serpooshan V; Sakhtianchi R; Müller B; Landfester K; Crespy D; Mahmoudi M
Colloids Surf B Biointerfaces; 2014 Nov; 123():143-9. PubMed ID: 25262409
[TBL] [Abstract][Full Text] [Related]
5. Nanostructures for protein drug delivery.
Pachioni-Vasconcelos Jde A; Lopes AM; Apolinário AC; Valenzuela-Oses JK; Costa JS; Nascimento Lde O; Pessoa A; Barbosa LR; Rangel-Yagui Cde O
Biomater Sci; 2016 Feb; 4(2):205-18. PubMed ID: 26580477
[TBL] [Abstract][Full Text] [Related]
6. Quantitative tracking of protein trafficking to the nucleus using cytosolic protein delivery by nanoparticle-stabilized nanocapsules.
Ray M; Tang R; Jiang Z; Rotello VM
Bioconjug Chem; 2015 Jun; 26(6):1004-7. PubMed ID: 26011555
[TBL] [Abstract][Full Text] [Related]
7. Rational Design of Nanocarriers for Intracellular Protein Delivery.
Qin X; Yu C; Wei J; Li L; Zhang C; Wu Q; Liu J; Yao SQ; Huang W
Adv Mater; 2019 Nov; 31(46):e1902791. PubMed ID: 31496027
[TBL] [Abstract][Full Text] [Related]
8. Shell-crosslinked hybrid nanoparticles for direct cytosolic delivery for tumor therapy.
He W; Jin Z; Lv Y; Cao H; Yao J; Zhou J; Yin L
Int J Pharm; 2015 Jan; 478(2):762-72. PubMed ID: 25529435
[TBL] [Abstract][Full Text] [Related]
9. Drug delivery to the eye: what benefits do nanocarriers offer?
Joseph RR; Venkatraman SS
Nanomedicine (Lond); 2017 Mar; 12(6):683-702. PubMed ID: 28186436
[TBL] [Abstract][Full Text] [Related]
10. Nanocapsules for Drug Delivery: An Updated Review of the Last Decade.
Erdoğar N; Akkın S; Bilensoy E
Recent Pat Drug Deliv Formul; 2018; 12(4):252-266. PubMed ID: 30674269
[TBL] [Abstract][Full Text] [Related]
11. Drug Delivery Vehicles Based on Albumin-Polymer Conjugates.
Jiang Y; Stenzel M
Macromol Biosci; 2016 Jun; 16(6):791-802. PubMed ID: 26947019
[TBL] [Abstract][Full Text] [Related]
12. Polymer micro- and nanocapsules as biological carriers with multifunctional properties.
Musyanovych A; Landfester K
Macromol Biosci; 2014 Apr; 14(4):458-77. PubMed ID: 24616298
[TBL] [Abstract][Full Text] [Related]
13. Clickable protein nanocapsules for targeted delivery of recombinant p53 protein.
Zhao M; Liu Y; Hsieh RS; Wang N; Tai W; Joo KI; Wang P; Gu Z; Tang Y
J Am Chem Soc; 2014 Oct; 136(43):15319-25. PubMed ID: 25289975
[TBL] [Abstract][Full Text] [Related]
14. Nanocarrier possibilities for functional targeting of bioactive peptides and proteins: state-of-the-art.
Moutinho CG; Matos CM; Teixeira JA; Balcão VM
J Drug Target; 2012 Feb; 20(2):114-41. PubMed ID: 22023555
[TBL] [Abstract][Full Text] [Related]
15. Nanocarriers for the treatment of glioblastoma multiforme: Current state-of-the-art.
Karim R; Palazzo C; Evrard B; Piel G
J Control Release; 2016 Apr; 227():23-37. PubMed ID: 26892752
[TBL] [Abstract][Full Text] [Related]
16. Applications of Nanoparticles for Anticancer Drug Delivery: A Review.
Zhu Y; Liao L
J Nanosci Nanotechnol; 2015 Jul; 15(7):4753-73. PubMed ID: 26373036
[TBL] [Abstract][Full Text] [Related]
17. Lipid nanocapsules for dermal application: a comparative study of lipid-based versus polymer-based nanocarriers.
Abdel-Mottaleb MM; Neumann D; Lamprecht A
Eur J Pharm Biopharm; 2011 Sep; 79(1):36-42. PubMed ID: 21558002
[TBL] [Abstract][Full Text] [Related]
18. Co-delivery of protein and small molecule therapeutics using nanoparticle-stabilized nanocapsules.
Kim CS; Mout R; Zhao Y; Yeh YC; Tang R; Jeong Y; Duncan B; Hardy JA; Rotello VM
Bioconjug Chem; 2015 May; 26(5):950-4. PubMed ID: 25894332
[TBL] [Abstract][Full Text] [Related]
19. A Bioinspired Platform for Effective Delivery of Protein Therapeutics to the Central Nervous System.
Wu D; Qin M; Xu D; Wang L; Liu C; Ren J; Zhou G; Chen C; Yang F; Li Y; Zhao Y; Huang R; Pourtaheri S; Kang C; Kamata M; Chen ISY; He Z; Wen J; Chen W; Lu Y
Adv Mater; 2019 May; 31(18):e1807557. PubMed ID: 30803073
[TBL] [Abstract][Full Text] [Related]
20. Mesoporous silica nanoparticles for intracellular controlled drug delivery.
Vivero-Escoto JL; Slowing II; Trewyn BG; Lin VS
Small; 2010 Sep; 6(18):1952-67. PubMed ID: 20690133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
